Adams isn't alone in her digestive distress
The reality is far more nuanced, and frankly, more interesting
GLP-1 receptor agonists significantly lowered CRP levels (standardised mean difference of 0.39) and TNF- levels (SMD of 0.51), with longer treatment durations yielding more noticeable benefits, according to a thorough meta-analysis published in 2025 that synthesised 25 studies involving 1,878 patients with type 2 diabetes
Clinical trials, such as Falutz et al., New England Journal of Medicine (2010), found significant reductions in VAT among patients treated with Tesamorelin
Finally, we will use Truvetas weight, BMI, and cardiovascular event data to study the comparative effectiveness of these medications
Evernorth, the health services division of The Cigna Group, announced the benefit that will make popular weight loss medications Wegovy and Zepbound more available to patients